Akorn Pharmaceuticals

Akorn Investor Relations

SEC Filings

Filing date Form Description Filing Group View
SC 13D/A

An amendment to a SC 13D filing

3,4,5
8-K

Report of unscheduled material events or corporate event

Current Reports
DEFA14A

Additional proxy soliciting materials - definitive

Proxy Filings
DEFA14A

Additional proxy soliciting materials - definitive

Proxy Filings
8-K

Report of unscheduled material events or corporate event

Current Reports
8-K

Report of unscheduled material events or corporate event

Current Reports
DEF 14A

Official notification to shareholders of matters to be brought to a vote ("Proxy")

Proxy Filings
PRE 14A

A preliminary proxy statement providing notification matters to be brought to a vote

Proxy Filings
8-K

Report of unscheduled material events or corporate event

Current Reports
8-K

Report of unscheduled material events or corporate event

Current Reports